Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases

Y. Komaki; A. Yamada; F. Komaki; D. Micic; A. Ido; A. Sakuraba

doi:10.1111/apt.14060

Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors’ reply

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.14060 ◽

2017 ◽

Vol 45 (10) ◽

pp. 1372-1372

Author(s):

Y. Komaki ◽

A. Yamada ◽

F. Komaki ◽

D. Micic ◽

A. Ido ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Inflammatory Bowel Diseases ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.14050 ◽

2017 ◽

Vol 45 (10) ◽

pp. 1370-1371 ◽

Cited By ~ 1

Author(s):

R. Felwick ◽

J. R. F. Cummings

Keyword(s):

Tumour Necrosis Factor ◽

Inflammatory Bowel Diseases ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

TUBERCULOSIS IN INFLAMMATORY BOWEL DISEASE UNDER TUMOUR NECROSIS FACTOR ALPHA ANTAGONIST – THE RISK BEYOND SCREENING

10.26226/morressier.59a6b34bd462b80290b559b1 ◽

2017 ◽

Author(s):

Carvalho Liliana

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Alpha Antagonist ◽

Necrosis Factor

Download Full-text

DOP007 Efficacy of vedolizumab induction therapy on clinical and endoscopic activity in patients with anti-tumour necrosis factor alpha-resistant inflammatory bowel disease

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.044 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S034-S035

Author(s):

R Bor ◽

F Klaudia ◽

P Miheller ◽

K Palatka ◽

T Szamosi ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Induction Therapy ◽

Bowel Disease ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12936 ◽

2014 ◽

Vol 40 (9) ◽

pp. 1035-1043 ◽

Cited By ~ 21

Author(s):

P. Deepak ◽

D. J. Stobaugh

Keyword(s):

Inflammatory Bowel Disease ◽

Adverse Events ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjv042 ◽

2015 ◽

Vol 9 (5) ◽

pp. 382-389 ◽

Cited By ~ 5

Author(s):

K. Karmiris ◽

P. Bossuyt ◽

D. Sorrentino ◽

T. Moreels ◽

A. Scarcelli ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Cerebrovascular Events ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors

International Journal of Oral and Maxillofacial Surgery ◽

10.1016/j.ijom.2019.08.007 ◽

2020 ◽

Vol 49 (3) ◽

pp. 317-324 ◽

Cited By ~ 3

Author(s):

K. Brijs ◽

I. Miclotte ◽

S. Vermeire ◽

V. Darche ◽

C. Politis

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Osteonecrosis Of The Jaw ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

P590. Therapeutic drug monitoring is a new tool for improving the care of patients treated by anti-tumour necrosis factor-alpha: Does this apply to children with inflammatory bowel diseases?

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw019.709 ◽

2016 ◽

Vol 10 (suppl 1) ◽

pp. S399.2-S400

Keyword(s):

Therapeutic Drug Monitoring ◽

Drug Monitoring ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Therapeutic Drug ◽

Necrosis Factor Alpha ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2007.03553.x ◽

2007 ◽

Vol 27 (1) ◽

pp. 19-30 ◽

Cited By ~ 69

Author(s):

V. S. THEIS ◽

J. M. RHODES

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Review Article ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Short-term histopathological response to anti-tumour necrosis factor alpha therapy in patients with ulcerative colitis

10.26226/morressier.596dfd59d462b80292387586 ◽

2017 ◽

Author(s):

Diana-Alexandra Costache

Keyword(s):

Ulcerative Colitis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Short Term ◽

Histopathological Response ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Therapy ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120210.576363 ◽

2008 ◽

Author(s):

John Atkinson

Keyword(s):

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Cord Factor ◽

Factor Alpha ◽

Necrosis Factor ◽

Granulomatous Response

Download Full-text